TUGAS INDIVIDU

MANAJEMEN STRATEGIK
CONTOH KASUS MATCHING STAGE PERUSAHAAN
JOHNSON&JOHNSON

Cindi Almira Permanaputri

C1C013011
FAKULTAS EKONOMI DAN BISNIS
UNIVERSITAS JENDERAL SOEDIRMAN

Current Vision :
To maximize the global power of diversity and inclusion to drive superior
business results and sustainable competitive advantage.

Johnson & Johnson Credo :

This is a statement of our values and responsibilities that was written more
than 60 years ago. It articulates our responsibilities to customers,
employees, communities and shareholders. It sets the tone for what is
expected at J&J.

Proposed Mission Statement :

1. Customers
2. Products or services
3. Markets
4. Technology.
5. Concern for survival, growth, and
Our philosophy and core values are centered on our desire to provide the
profitability
safest and most reliable products and services to our customers, employees,
medical professionals, and stockholders (1, 2, 6, and 9). Our consistent
6. Philosophy
market growth and competitive advantage within the world market will
ensure profitability and is a tribute to our trained employees, innovation,
7. Self-concept
technology, and market research (3, 4, and 5). In regards to local and
domestic
communities,
it is our goal to ensure that Johnson and Johnson
8. Concern
for public image
adhere to policies and procedures to be socially responsible and for the
betterment
allemployees
members of our value chain (7, 8).
9. Concernoffor
Proposed Vision Statement :
Johnson and Johnsons vision is to be the most recognized, innovative, and
socially responsible name in pharmaceutical, consumer health, medical
device, and prescription products in the world. Through this, we will earn our
customers respect and enthusiasm with continuous improvement that is
driven by innovation, integrity, teamwork, and the desire to provide value for

the investment. As a result, J&J will gain market share to increase sales and
generate dividends for our shareholders.

Proposed Slogan :
Caring for you from the beginning, to the very end!

External Assessment :

Position Map

CPM Matrix

Opportunities
Acquisition of Synthes could enhance J&Js Failure of prospective
products to deliver leadership position in global orthopedics
market
Leveraging therapeutic coverage of non-prescription
pharmaceutical segments could provide cross-selling
opportunities
Addition of Crucell to broaden J&Js position in biologics and
vaccines market
R&D investment will add to the potential growth rate of the
company in surrounding markets.
Economic recovery will be a boost in income thus company
revenue will increase.
Global expansion

Threats
o Negative Impact of Recent Product Recalls
o Healthcare regulations
o Better research and development of competitors
o Low market growth rate.
o Strong competition from the generic market.
o Launch success in that newly launch products are uncertain
because of regulatory review, thus making the launch a potential
threat if it fails.

 EFE Matrix

Strengths
Diverse business offering
Forecast growth despite challenges
Significant sales and marketing capabilities
Robust financial position
They have strong global presence operating in more than 57
countries with 250 subsidiary companies
They have successfully employed strategies to differentiation
that helps it distinguish itself from its competitors.

Weaknesses
o Generic drug's exposure
o Private label exposure
o Quality issues in OTC products affecting consumer healthcare
product sales
o Key product demand is shrinking.
o Theft and counterfeiting of drugs from internal staff as much as
this is not isolated to J&J.

Pressure to reduce prices in accordance with medical budgets

and maintain patent expirations to help generic programs.

IFE Matrix

SWOT Matrix

 Space Matrix

Grand Strategy Matrix

BCG Matrix

IE Matrix

Matrix Analysis

QSPM

Source :
http://perleybrook.umfk.maine.edu/slides/Spring2012/BUS411/Presentation%20J&J%202.ppt.